Prospective assessment of the clinical benefit of a tailored cancer gene set built on a next-generation sequencing platform in patients with recurrent or metastatic head and neck cancer
Journal article published in 2019 by
Thomas C. Westbrook,
Ian S. Hagemann,
Jessica Ley,
Kevin Chen,
Kevin Palka,
Jingxia Liu,
Ling Chen,
Peter Oppelt,
Douglas Adkins 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 